Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AbfiledCriticalAstra Ab
Priority to TNSN93097priorityCriticalpatent/TNSN93097A1/en
Publication of TNSN93097A1publicationCriticalpatent/TNSN93097A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
DES COMPOSES DE LA FORMULE GENERALE DANS LAQUELLE R EST UN ATOME D'HYDROGENE OU UN GROUPE PHENYLE, m EST UN ENTIER DE 3 A 8, R4 REPRESENTE UN GROUPE NO2 OU UN GROUPE NR7R8 DANS LEQUEL R7 ET R8 SONT IDENTIQUES OU DIFFERENTS ET CHACUN EST HYDROGENE OU ALKYLE. R5 EST SOIT HYDROGNE SOIT HALOGENE OU CF3. R6 EST HALOGENE OU CF3. W EST SOIT UN NOYAU(X) AROMATIQUE FACULTATIVEMENT SUBSTITUE SOIT UN NOYAU HETEROCYCLIQUE SOIT UN NOYAU(X) CARBOCYCLIQUE OU UN GROUPE METHYLENE FACULTATIVEMENT SUBSTITUE. A EST SOIT UN ATOME D'HYGIENE SOIT UN GROUPE HYDROXYLE SOIT UN ATOME D'HALOGENE SOIT CF3 SOIT UN GROUPE ALKYLE SOIT UN GROUPE ALKOXYLE SOIT UN GROUPE PHENYLE OU UN GROUPE PHENOXYLE. B EST UN ATOME D'HYDROGEN, OU A ET B CONSTITUENT ENSEMBLE UN GROUPE CARBONYLE. N1 EST 0 OU 1 ET N2 EST 0 OU 1 PROCEDES ET INTERMEDIAIRES POUR LEUR PREPARATION COMPOSITION PHARMACEUTIQUE LES CONTENANT ET USAGE DES COMPOSES DANS LE TRAITEMENT DES TROUBLES MENTAUXCOMPOUNDS OF THE GENERAL FORMULA IN WHICH R IS A HYDROGEN ATOM OR A PHENYL GROUP, m IS A WHOLE OF 3 TO 8, R4 REPRESENTS A GROUP NO2 OR A GROUP NR7R8 IN WHICH R7 AND R8 ARE THE SAME OR DIFFERENT AND EACH IS HYDROGEN OR ALKYL. R5 IS EITHER HYDROGNE OR HALOGEN OR CF3. R6 IS HALOGEN OR CF3. W IS EITHER AN OPTIONALLY SUBSTITUTED AROMATIC CORE (X) OR A HETEROCYCLIC CORE OR A CARBOCYCLIC CORE (X) OR AN OPTIONALLY SUBSTITUTED METHYLENE GROUP. A IS EITHER AN ATOM OF HYGIENE EITHER A HYDROXYL GROUP OR AN ATOM OF HALOGEN EITHER CF3 EITHER AN ALKYLE GROUP EITHER AN ALKOXYLE GROUP EITHER A PHENYL GROUP OR A PHENOXYL GROUP. B IS A HYDROGEN ATOM, OR A AND B TOGETHER CONSTITUTE A CARBONYL GROUP. N1 IS 0 OR 1 AND N2 IS 0 OR 1 METHODS AND INTERMEDIATES FOR THEIR PREPARATION PHARMACEUTICAL COMPOSITION CONTAINING THEM AND USE OF THE COMPOUNDS IN THE TREATMENT OF MENTAL DISORDERS
TNSN930971993-09-081993-09-08
NEW PIPERAZINES-AMIDOALKYLE AND -IMIDOALKYLE
TNSN93097A1
(en)
FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT ANVAENDBARA 5-SUBSTITUERADE OKTAHYDROINDOLIZINDERIVAT OCH VID FOERFARANDET ANVAENDBARA MELLANPRODUKTER.
(-) - 1Beta-ETHYL-1ALPHA-HYDROXYMETHYL-1,2,3,4,6,7,12,12beta alpha-OCTAHYDROINDOLO (2,3-a) QUINOLIZINE, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME .